Over the previous few years, there was a gradual inflow of startups making an attempt to deal with points like melancholy, interval ache, PMS, nervousness and insomnia by utilizing wearables that apply electrical, magnetic or ultrasonic alerts to stimulate the mind.
San Francisco-based Mave Health is the most recent of that fleet, and claims its $495, neuromodulation headset can enhance consideration and temper, regulate stress, and even measure psychological well being. The startup is positioning the wearable as a non-medical gadget so it gained’t want clearance from businesses just like the U.S. Meals and Drug Administration (FDA) to promote within the U.S.
Dhawal Jain, who began the corporate in 2023 together with his school batch mates Jai Sharma (CMO) and Aman Kumar (CTO), stated he realized the necessity for such a tool after his flatmate’s fiancée dedicated suicide in the course of the COVID-19 pandemic lockdowns.
“In India, committing suicide is against the law, which meant there was police concerned, and we needed to communicate to her psychologist. The solutions we acquired from them made us query if any of it made sense. We began connecting with different psychologists and had been getting the identical solutions,” Jain stated.
The founders felt that there was no tangible strategy to measure progress within the psychological well being house. “For instance, in case you ask a psychologist how are you aware if an individual is making progress, their response to it is rather normal, which is that it’s not about progress. It’s about course of […] However for anyone with melancholy who’s spending a whole lot of time in remedy, progress is necessary. So how are you aware whether or not they’re making progress or not? And even these primary questions weren’t being answered.”
In an effort to unravel that, the crew began to be taught extra about neuroscience by speaking to consultants, and shortly after realized that whereas there was progress round neuromodulation in labs, shoppers haven’t had the advantage of it.
The corporate then labored with medical gadget and psychological well being consultants to conduct trials of the know-how. However finally it took a special route and positioned its headset as a way of life gadget. Jain stated this method would let Mave attain a wider viewers.
Techcrunch occasion
San Francisco, CA
|
October 13-15, 2026
The gadget and know-how
Mave Well being’s gadget employs transcranial direct present stimulation (tDCS), a non-invasive approach to manage low-intensity currents to the mind to fireplace up neurons. The approach is usually utilized in psychology, and is alleged to be protected. Negative effects are gentle and non permanent, like itching or discomfort.
The headset delivers a low 1-2 mA present to stimulate the mind. The startup says prospects can use the gadget, which weighs roughly 100 grams, anytime, and recommends every day periods spanning 20 minutes for the primary few weeks of utilization.
The startup additionally offers an app that may measure long-term developments in temper, focus and stress ranges. It might probably additionally combine with different well being knowledge and observe measures like Coronary heart Fee Variability (HRV). Jain stated customers begin with a self-reported baseline evaluation once they begin, and full follow-up assessments each two to 4 weeks, which helps Mave perceive if the gadget helps a person in the long run.
The corporate hasn’t carried out any medical trials or revealed any research but. Nonetheless, Jain says it labored with greater than 500 customers in a non-public beta in 2024 and 2025, throughout which eight in ten customers reported a 60% improve in productiveness. The startup famous that 75% of its personal beta customers additionally reported a discount in stress from their baseline inside two months of utilization.
Mave Well being stated it has carried out 4 observational research throughout 200 contributors which are below educational evaluate with an purpose to publish this yr.
Dr. Himanshu Nirvan, a Delhi-based psychiatrist who labored with Mave Well being as a marketing consultant, stated that tDCS-based units are thought-about a confirmed strategy to deal with psychological health-related points. Nonetheless, he famous that he hasn’t seemed on the know-how from a way of life lens.
The corporate says it ran a program in India with Dr. Nirvan to check the gadget and the know-how.
“We did choose a whole lot of sufferers, and it was primarily an excellent program for my part. Issues like which are usually not very ceaselessly and simply obtainable even within the psychological well being administration house,” Dr. Nirvan stated. “I felt that for lots of people, tDCS is definitely fairly an excellent modality, contemplating that it’s a really moveable gadget. You may primarily cost it at residence, take it anyplace you need, even when you’re touring.”
Leigh Elkin Charvet, a medical neuropsychologist and Professor of Neurology at NYU Grossman Faculty of Medication, advised TechCrunch over electronic mail that whereas tDCS is taken into account a protected and efficient method to neuromodulation, units must be designed nicely to align electrodes correctly, and customers have to have common and constant periods.
“One problem is that customers might use the gadget with out medical screening or clear steerage about whether or not it’s acceptable for his or her signs. One other is that it may be troublesome for customers to find out whether or not the gadget is definitely serving to if outcomes will not be being measured in a structured approach,” she stated.
Charvet added that the usage of tDCS for broad life-style enhancement in wholesome people has not been studied broadly. “To date, many of the strongest analysis has centered on medical populations or structured cognitive coaching paradigms. We don’t but have clear steerage or robust proof supporting the usage of tDCS to enhance efficiency in in any other case wholesome people. A life-style use case should emerge, however that may depend on clearly defining goal outcomes and demonstrating that results are measurable and reproducible,” she stated.
The gadget is at present obtainable for pre-order, and the corporate is aiming to ship its first batch to prospects within the U.S. and India in April 2026.
The corporate not too long ago raised $2.1 million in a seed funding spherical led by Blume Ventures, with participation from particular person traders who embrace Tesla Autopilot AI lead Dhaval Shroff. The startup has raised slightly below $3 million in funding up to now.
